≡ MENU
Cell Therapies
Header5
Cell Therapies
Header4
Cell Therapies
Header1
Cell Therapies
Header2
Cell Therapies
Header3

CTPL awarded Australian Global Innovation Linkages programme grant

June 26th, 2017 |

Melbourne, Australia 26 June 2017: Cell Therapies has been awarded $1,000,000 in funding by the Australian Government Department of Industry, Innovation and Science through the Global Innovation Linkages programme.  On 10 April 2017, CTPL was announced as one of the nine successful Australian businesses and research organisations to be granted Round 1 funding to collaborate with global partners in science, research and development projects.

Cell Therapies was the lead applicant for the grant, forging a collaboration with 5 other organisations from Australia and the United States, to translate the development of an innovative dual-imaging cell tracking agent into cancer immunotherapy clinical studies as the next step towards commercialisation.

About Global Innovation Linkages Programme 

The Global Innovation Linkages programme provides funding to help Australian businesses and researchers to collaborate with global partners on strategically focused, leading-edge research and development projects.  More information about the Global Innovation Linkages programme is available at https://www.business.gov.au/assistance/global-innovation-linkages-programme.

About Cell Therapies Pty Ltd

Cell Therapies is a leading provider of cGMP contract manufacturing and deployment services for cell and gene therapy products in Asia Pacific. Cell Therapies is dedicated to enabling patient access to, and furthering the development of, these ground breaking therapies on behalf of clients from around the world. Building on more than 15 years’ experience and strategic partnerships with our owner, Peter MacCallum Cancer Centre in Melbourne Australia, we provide a complete process development and GMP product supply service from translational studies through to commercial supply and can serve as a single access point for Asian deployment of cellular therapies for our clients.